The science of drug safety and pharmacovigilance has become a cornerstone of the clinical research ecosystem in the GCC during the latter half of 2025, with Functional Service Providers playing a vital role in continuous risk assessment. As more multinational pharmaceutical entities conduct multicenter trials in the region, the need for a unified approach to adverse event reporting and safety...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt